Scholars Central

Conference abstractPublished 26 Aug 2013

Unresolved inflammation and aging: Joined forces in the induction of chronic diseases and cancer

Authors: Mahin Khatami

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

C laimed cancer ?personalized? medicine? or ?targeted? therapies which are based on the use of inhibitors of molecular components (e.g., gene mutations, growth factors, kinases) that identified in site-specific cancers demonstrated high rates of failure (85-95%) in the last few decades. The design of costly clinical trials and drugs that use potent apoptotic factors clearly indicate: a) poor, fragmented and fuzzy understanding of cancer biology that are costly to the cancer-stricken public; b) majority of ?targeted? drugs produce serious and life-threatening side effects such as drug-resistance, cancer relapse, cachexia, anorexia, multiple organ failure and death, symptoms that are similar to potent pathogen-induced acute inflammatory diseases such as sepsis, meningitis, salmonella poisoning, major trauma; c) an effective immune system provided via acute inflammation routinely monitors and destroy cancerous cells and other harmful components; and d) cancer only become a threat to body when immune system loses its effectiveness, particularly during aging. To better understand the forgotten but fundamental role of immune surveillance, this presentation will focus on the loss of cancer surveillance and chronic inflammation in the induction of a wide range of age-associated diseases or cancer. The results of our ?accidental? discoveries in 1980?s on experimental models of acute and chronic inflammatory diseases are suggestive of the first evidence for a direct association between inflammation and tumorigenesis and angiogenesis (Khatami et al 1984, 85, 88, 89, 91) and a first report on developmental phases of inflammation-induced immune dysfunction (Khatami 2005). These studies were extended at NCI/NIH since 1998 during design of clinical trials, utilization of patient biospecimen for cancer molecular diagnosis and prevention. Acute inflammation was defined as highly regulated cross talks, possessing 2 biologically opposing arms, ?Yin? (pro-inflammatory, apoptosis or tumoricidal) and ?Yang? (anti-inflammatory, wound healing or tumorigenic) between immune and non-immune systems (vasculature and neuro-endocrine). Chronic (oxidative stress, persistent or unresolved) inflammation was defined as loss of balance between ?Yin? and ?Yang? (tumoricidal v tumorigenic) of response profiles that could create immunological chaos in target tissues. Unresolved inflammation and severe alterations in immune dynamics, ?immune tsunami?, could differentially impact tissues that are naturally immune-responsive (e.g., epithelia, endothelia, stroma, vasculature) or immune-privileged (e.g., blood brain barrier/BBB, CNS, cornea, neuroretina, reproductive system, hair follicles) by damaging architectural integrity of tissues and induction of acute (e.g., sepsis, meningitis, respiratory failure ) and age-associated chronic diseases such as neurodegenerative and autoimmune diseases, diabetes and cardiovascular complications or cancer. Future directions in design of clinical trials will be proposed based on promotion of inherent ability of immune surveillance, or the maintenance of balance between ?Yin? and ?Yang? of acute inflammation. The ultimate goal is to help resolve the mystery around cancer biology and end the misery of cancer-stricken public.

Subjects

Engineering

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Tissue Science and Engineering.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Tissue Science and Engineering
  • SubjectEngineering
  • BylineArticles whose byline prints “Mahin Khatami”